Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2LPAPI
- Development stage
- Phase 4
- Lead developer
- Labo'Life
- Modality
- RNA Therapeutics → Nucleic Acid Therapeutics, Recombinant Proteins and Enzymes
- Administration
- Sublingual
01
Overview
2LPAPI is a micro-immunotherapy medicinal product developed by Labo'Life, authorized in Belgium for the treatment of high-risk human papillomavirus (HR-HPV) infections. It is formulated as sublingual globules and acts as an immune regulator designed to support the clearance of the virus. The product utilizes low-dose (homeopathic dilutions) cytokines, including Interleukin 1, Interleukin 2, and Interferon gamma, along with specific nucleic acids (SNA-PAPI) that target the viral genome. By modulating the immune response rather than directly attacking the virus, 2LPAPI aims to restore the body's natural defense mechanisms against HR-HPV. It is currently being evaluated in randomized, placebo-controlled clinical trials to further establish its efficacy in clearing genital HR-HPV infections.
- Brand names
- 2LPAPI
- Other names
- 2L PAPI
02
Targets
HR-HPV (High-risk human papillomavirus genomes and transcripts)
Beyond the preview
Go deeper on 2LPAPI.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2LPAPI.